Brief: Chimeric Therapeutics Announces Entitlement Offer To Raise About A$18.1 Mln
Feb 21 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* ENTITLEMENT OFFER TO RAISE ABOUT A$18.1 MILLION
* INTENDS TO CONDUCT AN EQUITY RAISING VIA ACCELERATED 1 FOR
3.15
NON-RENOUNCEABLE ENTITLEMENT OFFER
* OFFER PRICE FOR ENTITLEMENT OFFER WILL BE A$0.17 PER SHARE
Source text for Eikon: ID:nASX1fZ1bL
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial